Arkolith/Insider Trading/TMBR/Form 4

TardiMed Sciences LLC

10% OwnerTimber Pharmaceuticals, Inc. (TMBR) · full profile →Form 4 · filed Jun 15, 2021
Net Selling
Open-Market Buys
$0
Open-Market Sells
$222K
Net Open-Market Flow
-$222K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 15, 2021Sell(S)28K$1.26$36K4.6M
Jun 14, 2021Sell(S)146K$1.27$186K4.6M

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-21-081618) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML